Epidemiological and ethical aspects of multiplex autoantibody testing

Area of Science:

• Biotechnology
• Immunology
• Statistical Genetics

Background:

• Array technologies allow simultaneous detection of thousands of markers from a single biological sample.
• The primary goal of diagnostic testing is early and accurate diagnosis.
• Multiple testing in arrays increases the probability of false positive and false negative results.

Purpose of the Study:

• To highlight the statistical challenges in array-based diagnostics, specifically multiple testing.
• To discuss the ethical considerations surrounding diagnostic testing, including autonomy, informed consent, and privacy.
• To emphasize the importance of discussing test implications and treatment options.

Main Methods:

• Utilizing array-based technologies for high-throughput autoantibody detection.
• Applying statistical correction methods such as family-wise error rate (FWER) and false discovery rate (FDR).
• Ethical framework analysis for diagnostic test decision-making.

Main Results:

• Multiple testing in arrays necessitates statistical corrections to manage false positives and negatives.
• Ethical considerations are paramount, requiring autonomous decision-making, informed consent, and privacy protection.
• The benefits of early versus late treatment must be weighed against potential harms and uncertainties.

Conclusions:

• Array-based autoantibody detection requires careful statistical management of multiple testing.
• Ethical discussions regarding test necessity, implications, and patient autonomy are crucial.
• Informed decision-making balances potential benefits of early treatment with risks and uncertainties.